Phibro Animal Health Corporation (PAHC)
Makes medicines, vaccines, and mineral supplements for livestock and pets.
$36.37+0.03%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+39.3%
The outlook
PAHC is trading near the lower end of its 52-week range, sitting about a third of the way from its lows to highs. Analysts see meaningful upside, with an average target around 24% above the current price, though the stock is mixed relative to its moving averages. The neutral overall score reflects mixed positioning in the current market context.
What’s behind the score
Price trendMixed vs its moving averages
52-week range31% of the way from its 52-week low to high
Price targetAvg target +24% vs current price
Analyst price target
~12-month · 5 analysts$45.00average target+23.7% vs now
Now $36.37
Low $35.00High $58.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.48B
52-wk high
$60.08
52-wk low
$25.58
50-day avg
$32.60
200-day avg
$42.63
Trailing P/E
15.1